165 related articles for article (PubMed ID: 18809221)
1. The active metabolite of leflunomide, A77 1726, protects rat hepatocytes against bile acid-induced apoptosis.
Vrenken TE; Buist-Homan M; Kalsbeek AJ; Faber KN; Moshage H
J Hepatol; 2008 Nov; 49(5):799-809. PubMed ID: 18809221
[TBL] [Abstract][Full Text] [Related]
2. Pertussis toxin, an inhibitor of G(αi) PCR, inhibits bile acid- and cytokine-induced apoptosis in primary rat hepatocytes.
Karimian G; Buist-Homan M; Faber KN; Moshage H
PLoS One; 2012; 7(8):e43156. PubMed ID: 22900098
[TBL] [Abstract][Full Text] [Related]
3. Metformin protects rat hepatocytes against bile acid-induced apoptosis.
Woudenberg-Vrenken TE; Conde de la Rosa L; Buist-Homan M; Faber KN; Moshage H
PLoS One; 2013; 8(8):e71773. PubMed ID: 23951244
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II protects primary rat hepatocytes against bile salt-induced apoptosis.
Karimian G; Buist-Homan M; Mikus B; Henning RH; Faber KN; Moshage H
PLoS One; 2012; 7(12):e52647. PubMed ID: 23300732
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression.
Manna SK; Aggarwal BB
J Immunol; 1999 Feb; 162(4):2095-102. PubMed ID: 9973483
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide or A77 1726 protect from acetaminophen-induced cell injury through inhibition of JNK-mediated mitochondrial permeability transition in immortalized human hepatocytes.
Latchoumycandane C; Seah QM; Tan RC; Sattabongkot J; Beerheide W; Boelsterli UA
Toxicol Appl Pharmacol; 2006 Nov; 217(1):125-33. PubMed ID: 16979204
[TBL] [Abstract][Full Text] [Related]
7. An active metabolite of leflunomide, A77 1726, inhibits the production of serum amyloid A protein in human hepatocytes.
Migita K; Miyashita T; Maeda Y; Nakamura M; Yatsuhashi H; Ishibashi H; Eguchi K
Rheumatology (Oxford); 2005 Apr; 44(4):443-8. PubMed ID: 15695308
[TBL] [Abstract][Full Text] [Related]
8. Effects of the active metabolite of leflunomide, A77 1726, on cytokine release and the MAPK signalling pathway in human rheumatoid arthritis synoviocytes.
Vergne-Salle P; Léger DY; Bertin P; Trèves R; Beneytout JL; Liagre B
Cytokine; 2005 Sep; 31(5):335-48. PubMed ID: 16099671
[TBL] [Abstract][Full Text] [Related]
9. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
Schoemaker MH; Conde de la Rosa L; Buist-Homan M; Vrenken TE; Havinga R; Poelstra K; Haisma HJ; Jansen PL; Moshage H
Hepatology; 2004 Jun; 39(6):1563-73. PubMed ID: 15185297
[TBL] [Abstract][Full Text] [Related]
10. The active metabolite of leflunomide, A77 1726, attenuates inflammatory arthritis in mice with spontaneous arthritis via induction of heme oxygenase-1.
Moon SJ; Kim EK; Jhun JY; Lee HJ; Lee WS; Park SH; Cho ML; Min JK
J Transl Med; 2017 Feb; 15(1):31. PubMed ID: 28193225
[TBL] [Abstract][Full Text] [Related]
11. Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.
Rust C; Bauchmuller K; Bernt C; Vennegeerts T; Fickert P; Fuchsbichler A; Beuers U
Gut; 2006 May; 55(5):719-27. PubMed ID: 16322111
[TBL] [Abstract][Full Text] [Related]
12. The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes.
Palmer G; Burger D; Mezin F; Magne D; Gabay C; Dayer JM; Guerne PA
Arthritis Res Ther; 2004; 6(3):R181-9. PubMed ID: 15142263
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of the active metabolite of leflunomide, A77 1726, on feline herpesvirus-1.
Williams CR; Sykes JE; Mehl M; MacLeod JS; Lindsay LL; Poland AM; Chen YJ; Kyles AE; Waldman WJ; Gregory CR
Am J Vet Res; 2007 Sep; 68(9):1010-5. PubMed ID: 17764417
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress.
Doscas ME; Williamson AJ; Usha L; Bogachkov Y; Rao GS; Xiao F; Wang Y; Ruby C; Kaufman H; Zhou J; Williams JW; Li Y; Xu X
Neoplasia; 2014 Oct; 16(10):824-34. PubMed ID: 25379019
[TBL] [Abstract][Full Text] [Related]
15. Anti-oxidants do not prevent bile acid-induced cell death in rat hepatocytes.
Woudenberg-Vrenken TE; Buist-Homan M; Conde de la Rosa L; Faber KN; Moshage H
Liver Int; 2010 Nov; 30(10):1511-21. PubMed ID: 20825559
[TBL] [Abstract][Full Text] [Related]
16. The active metabolite of leflunomide, A77 1726, increases proliferation of human synovial fibroblasts in presence of IL-1beta and TNF-alpha.
Magne D; Mézin F; Palmer G; Guerne PA
Inflamm Res; 2006 Nov; 55(11):469-75. PubMed ID: 17122964
[TBL] [Abstract][Full Text] [Related]
17. Hepatic cytochrome P450s attenuate the cytotoxicity induced by leflunomide and its active metabolite A77 1726 in primary cultured rat hepatocytes.
Shi Q; Yang X; Greenhaw J; Salminen WF
Toxicol Sci; 2011 Aug; 122(2):579-86. PubMed ID: 21546349
[TBL] [Abstract][Full Text] [Related]
18. Oxidative bioactivation and toxicity of leflunomide in immortalized human hepatocytes and kinetics of the non-enzymatic conversion to its major metabolite, A77 1726.
Seah QM; New LS; Chan EC; Boelsterli UA
Drug Metab Lett; 2008 Aug; 2(3):153-7. PubMed ID: 19356086
[TBL] [Abstract][Full Text] [Related]
19. Scopoletin and umbelliferone protect hepatocytes against palmitate- and bile acid-induced cell death by reducing endoplasmic reticulum stress and oxidative stress.
Wu Z; Geng Y; Buist-Homan M; Moshage H
Toxicol Appl Pharmacol; 2022 Feb; 436():115858. PubMed ID: 34979142
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis.
Karimian G; Buist-Homan M; Schmidt M; Tietge UJ; de Boer JF; Klappe K; Kok JW; Combettes L; Tordjmann T; Faber KN; Moshage H
Biochim Biophys Acta; 2013 Dec; 1832(12):1922-9. PubMed ID: 23816565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]